Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Hematology/Oncology ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- The history and evolution of radiotherapy and radiation oncology in Austria.Int J Radiat Oncol Biol Phys. 1996; 35: 219-226
- Radiobiology for the radiologist.Wolters Kluwer, Philadelphia2019
- Four R's of radiotherapy.Advances in Radiation Biology. 1975; 5: 241-271
- The 5Rs of radiobiology.Int J Radiat Biol. 1989; 56: 1045-1048
- Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC).Int J Radiat Oncol Biol Phys. 1995; 31: 1341-1346
- Tolerance of normal tissue to therapeutic irradiation.Int J Radiat Oncol Biol Phys. 1991; 21: 109-122
- Use of normal tissue complication probability models in the clinic.Int J Radiat Oncol Biol Phys. 2010; 76: S10-S19
- Multimodality management of cerebral arteriovenous malformations.Handb Clin Neurol. 2017; 143: 85-96
- A practical grading scale for predicting outcome after radiosurgery for arteriovenous malformations: analysis of 1012 treated patients.J Neurosurg. 2013; 119: 981-987
- Cerebral arteriovenous malformations: evaluation and management.ScientificWorldJournal. 2014; 2014: 649036
- The risk of hemorrhage after radiosurgery for cerebral arteriovenous malformations.N Engl J Med. 2005; 352: 146-153
- Prospective staged volume radiosurgery for large arteriovenous malformations: indications and outcomes in otherwise untreatable patients.Neurosurgery. 2008; 62: 744-754
- Leksell gamma knife radiosurgery for cerebral arteriovenous malformations in pediatric patients.Childs Nerv Syst. 2005; 21 ([discussion: 308]): 301-307
- Risk reduction of cerebral stroke after stereotactic radiosurgery for small unruptured brain arteriovenous malformations.Stroke. 2016; 47: 1247-1252
- Radiosurgery for cerebral arteriovenous malformations in elderly patients: effect of advanced age on outcomes after intervention.World Neurosurg. 2015; 84: 795-804
- Gamma Knife surgery for incidental cerebral arteriovenous malformations.J Neurosurg. 2014; 121: 1015-1021
- Stereotactic proton beam therapy for intracranial arteriovenous malformations.Int J Radiat Oncol Biol Phys. 2005; 62: 44-52
- Treatment outcome after linac-based radiosurgery in cerebral arteriovenous malformations: retrospective analysis of factors affecting obliteration.Radiother Oncol. 2005; 77: 105-110
- Efficacy and morbidity of arc-therapy radiosurgery for cerebral arteriovenous malformations: a comparison with the natural history.Int J Radiat Oncol Biol Phys. 2004; 58: 1353-1363
- Update on desmoid tumors.Ann Oncol. 2012; 23: 562-569
- The role of adjuvant radiotherapy in the treatment of resectable desmoid tumors.Int J Radiat Oncol Biol Phys. 1997; 39: 659-665
- A nation-wide study comparing sporadic and familial adenomatous polyposis-related desmoid-type fibromatoses.Int J Cancer. 2011; 129: 256-261
- Desmoid tumor patients carry an elevated risk of familial adenomatous polyposis.J Surg Oncol. 2016; 113: 209-212
- Prognostic factors influencing progression-free survival determined from a series of sporadic desmoid tumors: a wait-and-see policy according to tumor presentation.J Clin Oncol. 2011; 29: 3553-3558
- Spontaneous regression of primary abdominal wall desmoid tumors: more common than previously thought.Ann Surg Oncol. 2013; 20: 4096-4102
- Chest-wall desmoid tumors: results of surgical intervention.Ann Thorac Surg. 2004; 78 ([discussion: 1219–23]): 1219-1223
- Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy.J Clin Oncol. 1999; 17: 158-167
- Extremity and trunk desmoid tumors: a multifactorial analysis of outcome.Cancer. 1999; 86: 2045-2052
- A prognostic nomogram for prediction of recurrence in desmoid fibromatosis.Ann Surg. 2013; 258: 347-353
- Radiation therapy in the management of desmoid tumors.Int J Radiat Oncol Biol Phys. 1998; 42: 1007-1014
- Results of a phase II pilot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis--an EORTC STBSG and ROG study (EORTC 62991-22998).Ann Oncol. 2013; 24: 2672-2676
- External beam radiotherapy for primary and adjuvant management of aggressive fibromatosis.Int J Radiat Oncol Biol Phys. 2002; 54: 177-181
- Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution.J Clin Oncol. 2003; 21: 1390-1397
- Meta-analysis of the influence of surgical margin and adjuvant radiotherapy on local recurrence after resection of sporadic desmoid-type fibromatosis.Br J Surg. 2017; 104: 347-357
- Preoperative radiotherapy is effective in the treatment of fibromatosis.Clin Orthop Relat Res. 2003; : 19-24
- Desmoid tumours treated with triphenylethylenes.Eur J Cancer. 1992; 28A: 1014-1018
- Desmoids: a revelation in biology and treatment.Ann Surg Oncol. 2009; 16: 1650-1654
- Radiotherapy of early stage Dupuytren disease. Long-term results after a median follow-up period of 10 years.Strahlenther Onkol. 2001; 177 ([in German]): 604-610
- Radiotherapy in Dupuytren's disease: a systematic review of the evidence.J Hand Surg Eur. 2017; 42: 689-692
- Radiotherapy for prevention of disease progression in early-stage Dupuytren's contracture: initial and long-term results.Int J Radiat Oncol Biol Phys. 1996; 36: 891-897
- Radiotherapy optimization in early-stage Dupuytren's contracture: first results of a randomized clinical study.Int J Radiat Oncol Biol Phys. 2001; 49: 785-798
- Radiotherapy in early-stage Dupuytren's contracture. Long-term results after 13 years.Strahlenther Onkol. 2010; 186: 82-90
- Patient-reported outcomes after electron radiation treatment for early-stage palmar and plantar fibromatosis.Pract Radiat Oncol. 2015; 5: e651-e658
- Radiotherapy with soft X-rays in Dupuytren's disease - successful, well-tolerated and satisfying.J Eur Acad Dermatol Venereol. 2015; 29: 904-911
- Dosimetric comparison of radiation methods for palmar fibrosis.J Clin Radiat Oncol. 2017; 2: 1-3
- Estimation of cancer risks from radiotherapy of benign diseases.Strahlenther Onkol. 2006; 182: 431-436
- Graves' ophthalmopathy: a preventable disease?.Eur J Endocrinol. 2002; 146: 457-461
- Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed graves' hyperthyroidism seen at a single center.J Clin Endocrinol Metab. 2013; 98: 1443-1449
- Clinical review 157: Pathophysiology of Graves' ophthalmopathy: the cycle of disease.J Clin Endocrinol Metab. 2003; 88: 1939-1946
- Graves' ophthalmopathy.N Engl J Med. 2010; 362: 726-738
- Surgical or medical decompression as a first-line treatment of optic neuropathy in Graves' ophthalmopathy? A randomized controlled trial.Clin Endocrinol (Oxf). 2005; 63: 323-328
- [The role of radiotherapy in Graves' ophthalmopathy].J Fr Ophtalmol. 2004; 27: 825-827
- Treating severe Graves' ophthalmopathy.Baillieres Clin Endocrinol Metab. 1997; 11: 521-536
- Radiotherapy for Graves' ophthalmopathy: results at one year.Thyroid. 2002; 12: 251-255
- A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves' ophthalmopathy.J Clin Endocrinol Metab. 2004; 89: 15-20
- Radiotherapy for Graves' orbitopathy: randomised placebo-controlled study.Lancet. 2000; 355: 1505-1509
- Retrobulbar irradiation for Graves' ophthalmopathy -- long-term results.Klin Monbl Augenheilkd. 2002; 219 ([in German]): 876-882
- Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study.J Clin Endocrinol Metab. 2001; 86: 3562-3567
- Treatment modalities for Graves' ophthalmopathy: systematic review and metaanalysis.J Clin Endocrinol Metab. 2009; 94: 2708-2716
- Does radiotherapy have a role in the management of thyroid orbitopathy? View 1.Br J Ophthalmol. 2002; 86: 102-104
- Relationship between management of hyperthyroidism and course of the ophthalmopathy.J Endocrinol Invest. 2004; 27: 288-294
- Orbital radiotherapy for Graves' ophthalmopathy: useful or useless? Safe or dangerous?.J Endocrinol Invest. 2003; 26: 5-16
- Radiotherapy for moderate-to-severe Graves' ophthalmopathy: improved outcomes with early treatment.Cancer J. 2003; 9: 472-475
- Effectiveness of treatment for thyroid orbitopathy in patients hospitalized at the Endocrinology Department of Pomeranian Medical University.Przegl Lek. 2004; 61 ([in Polish]): 852-854
- Place of radiotherapy in the treatment of Graves' orbitopathy.Int J Radiat Oncol Biol Phys. 1999; 43: 805-815
- Orbital irradiation for Graves' ophthalmopathy: Is it safe? A long-term follow-up study.Ophthalmology. 2004; 111: 1557-1562
- Radiation retinopathy after standard radiotherapy for thyroid-related ophthalmopathy.Am J Ophthalmol. 1991; 112: 600-601
- Long-term safety of orbital radiotherapy for Graves' ophthalmopathy.J Clin Endocrinol Metab. 2003; 88: 3561-3566
- Clinical outcomes of graves' ophthalmopathy treated with intensity modulated radiation therapy.Radiat Oncol. 2017; 12: 171
- Bicalutamide as immediate therapy either alone or as adjuvant to standard care of patients with localized or locally advanced prostate cancer: first analysis of the early prostate cancer program.J Urol. 2002; 168: 429-435
- EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.Eur Urol. 2014; 65: 467-479
- The safety and tolerability of low-dose irradiation for the management of gynaecomastia caused by antiandrogen monotherapy.Lancet Oncol. 2003; 4: 30-36
- Gynaecomastia: aetiology and treatment options.Prostate Cancer Prostatic Dis. 1999; 2: 167-171
- Does prophylactic breast irradiation prevent antiandrogen-induced gynecomastia? Evaluation of 253 patients in the randomized Scandinavian trial SPCG-7/SFUO-3.Urology. 2003; 61: 145-151
- Is prophylactic breast radiotherapy necessary in all patients with prostate cancer and gynecomastia and/or breast pain?.J Urol. 2010; 184: 519-524
- Efficacy of tamoxifen and radiotherapy for prevention and treatment of gynaecomastia and breast pain caused by bicalutamide in prostate cancer: a randomised controlled trial.Lancet Oncol. 2005; 6: 295-300
- Efficacy and tolerability of radiotherapy as treatment for bicalutamide-induced gynaecomastia and breast pain in prostate cancer.Eur Urol. 2005; 47: 587-592
- Prophylactic breast irradiation with a single dose of electron beam radiotherapy (10 Gy) significantly reduces the incidence of bicalutamide-induced gynecomastia.Int J Radiat Oncol Biol Phys. 2004; 60: 476-483
- Prevention of gynecomastia and breast pain caused by androgen deprivation therapy in prostate cancer: tamoxifen or radiotherapy?.Int J Radiat Oncol Biol Phys. 2012; 83: e519-e524
- Gynecomastia in Patients with Prostate Cancer: A Systematic Review.PLoS One. 2015; 10: e0136094
- Gynecomastia due to hormone therapy for advanced prostate cancer: a report of ten surgically treated cases and a review of treatment options.Tumori. 2004; 90: 410-415
- Aromatase inhibitors in men: effects and therapeutic options.Reprod Biol Endocrinol. 2011; 9: 93
- Effective radiotherapy in palliating mammalgia associated with gynecomastia after DES therapy.Int J Radiat Oncol Biol Phys. 1988; 15: 749-751
- Does prophylactic radiation therapy to avoid gynecomastia in patients with prostate cancer increase the risk of breast cancer?.Int J Radiat Oncol Biol Phys. 2018; 101: 211-216
- Incidence of heterotopic bone formation after major hip surgery.ANZ J Surg. 2002; 72: 808-821
- Randomized trial comparing preoperative versus postoperative irradiation for prevention of heterotopic ossification following prosthetic total hip replacement: preliminary results.Int J Radiat Oncol Biol Phys. 1994; 30: 55-62
- Ectopic ossification following total hip replacement. Incidence and a method of classification.J Bone Joint Surg Am. 1973; 55: 1629-1632
- Does indomethacin reduce heterotopic bone formation after operations for acetabular fractures? A prospective randomised study.J Bone Joint Surg Br. 1997; 79: 959-963
- Prevention of heterotopic bone formation after total hip arthroplasty: a prospective randomised study comparing postoperative radiation therapy with indomethacin medication.Arch Orthop Trauma Surg. 1999; 119: 296-302
- Radiotherapy vs. nonsteroidal anti-inflammatory drugs for the prevention of heterotopic ossification after major hip procedures: a meta-analysis of randomized trials.Int J Radiat Oncol Biol Phys. 2004; 60: 888-895
- The role of radiation dose in a combined therapeutic protocol for the prevention of heterotopic ossification after total hip replacement.J BUON. 2010; 15: 74-78
- Radiation prophylaxis for heterotopic ossification about the hip joint--a multicenter study.Int J Radiat Oncol Biol Phys. 2001; 51: 756-765
- Heterotopic bone formation after hip surgery: prevention with single-dose postoperative hip irradiation.Radiology. 1988; 168: 851-854
- Prevention of heterotopic ossification with irradiation after total hip arthroplasty. Radiation therapy with a single dose of eight hundred centigray administered to a limited field.J Bone Joint Surg Am. 1992; 74: 186-200
- Single-dose irradiation for the prevention of heterotopic ossification after total hip arthroplasty. A comparison of doses of five hundred and fifty and seven hundred centigray.J Bone Joint Surg Am. 1995; 77: 590-595
- Prevention of heterotopic ossification about the hip: final results of two randomized trials in 410 patients using either preoperative or postoperative radiation therapy.Int J Radiat Oncol Biol Phys. 1997; 39: 161-171
- The efficacy of 500 CentiGray radiation in the prevention of heterotopic ossification after total hip arthroplasty: a prospective, randomized, pilot study.J Arthroplasty. 2003; 18: 677-686
- Heterotopic ossification prophylaxis with indomethacin increases the risk of long-bone nonunion.J Bone Joint Surg Br. 2003; 85: 700-705
- Radiation-induced sarcoma following radiation prophylaxis of heterotopic ossification.Pract Radiat Oncol. 2012; 2: 151-154
- Histiocytosis X. Langerhans' cell histiocytosis.Hematol Oncol Clin North Am. 1987; 1: 737-751
- Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells.J Immunol. 2010; 184: 4557-4567
- BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups.J Exp Med. 2014; 211: 669-683
- The variable presentation and natural history of Langerhans cell histiocytosis.Iowa Orthop J. 1999; 19: 99-105
- The histiocytoses: the fall of the tower of babel.Eur J Cancer. 1999; 35 ([discussion 767–9]): 747-767
- Risk factors for diabetes insipidus in langerhans cell histiocytosis.Pediatr Blood Cancer. 2006; 46: 228-233
- Percutaneous techniques for the diagnosis and treatment of localized Langerhans-cell histiocytosis (eosinophilic granuloma of bone).J Bone Joint Surg Am. 1998; 80: 219-228
- Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensification.Blood. 2008; 111: 2556-2562
- Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis.Blood. 2013; 121: 5006-5014
- A randomized trial of treatment for multisystem Langerhans' cell histiocytosis.J Pediatr. 2001; 138: 728-734
- Adult langerhans cell histiocytosis of bones : a rare cancer network study.Acta Orthop Belg. 2010; 76: 663-668
- Histiocytosis X: does radiotherapy still have a role?.Clin Oncol (R Coll Radiol). 1992; 4: 27-31
- Radiation therapy in the management of Langerhans cell histiocytosis.Med Pediatr Oncol. 1990; 18: 97-102
- Eosinophilic granuloma of the cervical spine.Spine (Phila Pa 1976). 2002; 27: 1408-1413
- Histiocytosis X in bone only.Med Pediatr Oncol. 1990; 18: 292-294
- Outcome after radiation therapy for langerhans cell histiocytosis is dependent on site of involvement.Int J Radiat Oncol Biol Phys. 2018; 100: 670-678
- Radiotherapy dose fractionation in pediatric Langerhans cell histiocytosis.South Med J. 2004; 97: 1268-1269
- Radiation therapy in children: continued need to assess risk versus gain.Int J Radiat Oncol Biol Phys. 1992; 23: 675-676
- The role of radiation therapy in the management of children with histiocytosis X.Am J Pediatr Hematol Oncol. 1981; 3: 161-163
- Clinical outcomes of radiation therapy in the management of Langerhans cell histiocytosis.Am J Clin Oncol. 2014; 37: 592-596
- Diabetes insipidus secondary to Langerhans' cell histiocytosis: is radiation therapy indicated?.Med Pediatr Oncol. 1997; 29: 36-40
- Radiation therapy for diabetes insipidus caused by Langerhans cell histiocytosis.Int J Radiat Oncol Biol Phys. 1992; 23: 519-524
Article info
Publication history
Published online: October 28, 2019
Footnotes
This is an update of an article that first appeared in the Hematology/Oncology Clinics of North America, Volume 20, Issue 2, April 2006.
Disclosure Statement: All authors have nothing to disclose.
Identification
Copyright
© 2019 Elsevier Inc. All rights reserved.
